vs

Side-by-side financial comparison of Ivanhoe Electric Inc. (IE) and Insight Molecular Diagnostics Inc. (IMDX). Click either name above to swap in a different company.

Insight Molecular Diagnostics Inc. is the larger business by last-quarter revenue ($1.1M vs $896.0K, roughly 1.3× Ivanhoe Electric Inc.). Insight Molecular Diagnostics Inc. runs the higher net margin — -2015.4% vs -4500.4%, a 2485.1% gap on every dollar of revenue. On growth, Insight Molecular Diagnostics Inc. posted the faster year-over-year revenue change (-23.4% vs -32.7%). Insight Molecular Diagnostics Inc. produced more free cash flow last quarter ($-7.0M vs $-25.7M). Over the past eight quarters, Insight Molecular Diagnostics Inc.'s revenue compounded faster (154.4% CAGR vs 57.8%).

Ivanhoe Electric Inc. is a critical minerals exploration and development firm focused on metals for global electrification. It targets high-grade copper, gold, silver and strategic deposits, with primary North American operations, supplying raw materials to renewable energy, EV and power grid infrastructure supply chains worldwide.

Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.

IE vs IMDX — Head-to-Head

Bigger by revenue
IMDX
IMDX
1.3× larger
IMDX
$1.1M
$896.0K
IE
Growing faster (revenue YoY)
IMDX
IMDX
+9.4% gap
IMDX
-23.4%
-32.7%
IE
Higher net margin
IMDX
IMDX
2485.1% more per $
IMDX
-2015.4%
-4500.4%
IE
More free cash flow
IMDX
IMDX
$18.7M more FCF
IMDX
$-7.0M
$-25.7M
IE
Faster 2-yr revenue CAGR
IMDX
IMDX
Annualised
IMDX
154.4%
57.8%
IE

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IE
IE
IMDX
IMDX
Revenue
$896.0K
$1.1M
Net Profit
$-40.3M
$-23.0M
Gross Margin
69.5%
42.5%
Operating Margin
-4167.7%
-2057.5%
Net Margin
-4500.4%
-2015.4%
Revenue YoY
-32.7%
-23.4%
Net Profit YoY
-318.3%
31.5%
EPS (diluted)
$0.24
$-0.75

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IE
IE
IMDX
IMDX
Q4 25
$896.0K
$1.1M
Q3 25
$545.0K
$260.0K
Q2 25
$1.1M
$518.0K
Q1 25
$735.0K
$2.1M
Q4 24
$1.3M
$1.5M
Q3 24
$671.0K
$115.0K
Q2 24
$538.0K
$104.0K
Q1 24
$360.0K
$176.0K
Net Profit
IE
IE
IMDX
IMDX
Q4 25
$-40.3M
$-23.0M
Q3 25
$-17.5M
$-10.9M
Q2 25
$-23.9M
$-9.7M
Q1 25
$-34.1M
$-6.7M
Q4 24
$18.5M
$-33.5M
Q3 24
$-43.2M
$-13.5M
Q2 24
$-46.8M
$-4.5M
Q1 24
$-60.1M
$-9.1M
Gross Margin
IE
IE
IMDX
IMDX
Q4 25
69.5%
42.5%
Q3 25
51.2%
53.5%
Q2 25
72.5%
67.6%
Q1 25
60.1%
62.0%
Q4 24
64.7%
40.0%
Q3 24
61.8%
43.5%
Q2 24
64.3%
48.1%
Q1 24
72.2%
25.6%
Operating Margin
IE
IE
IMDX
IMDX
Q4 25
-4167.7%
-2057.5%
Q3 25
-4328.3%
-4249.2%
Q2 25
-2400.3%
-1900.0%
Q1 25
-3674.0%
-318.0%
Q4 24
-2229.4%
-2262.9%
Q3 24
-6233.8%
-11752.2%
Q2 24
-9023.4%
-4453.8%
Q1 24
-15800.3%
-5265.3%
Net Margin
IE
IE
IMDX
IMDX
Q4 25
-4500.4%
-2015.4%
Q3 25
-3214.9%
-4174.6%
Q2 25
-2233.2%
-1880.7%
Q1 25
-4645.0%
-312.0%
Q4 24
1386.6%
-2255.1%
Q3 24
-6443.5%
-11733.0%
Q2 24
-8695.7%
-4355.8%
Q1 24
-16693.1%
-5186.9%
EPS (diluted)
IE
IE
IMDX
IMDX
Q4 25
$0.24
$-0.75
Q3 25
$0.13
$-0.34
Q2 25
$0.18
$-0.30
Q1 25
$0.24
$-0.26
Q4 24
$-0.14
$-2.19
Q3 24
$0.36
$-0.98
Q2 24
$0.39
$-0.36
Q1 24
$0.46
$-1.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IE
IE
IMDX
IMDX
Cash + ST InvestmentsLiquidity on hand
$173.3M
$11.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$416.1M
$-31.5M
Total Assets
$483.3M
$25.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IE
IE
IMDX
IMDX
Q4 25
$173.3M
$11.6M
Q3 25
$69.5M
$18.7M
Q2 25
$88.0M
$24.3M
Q1 25
$98.2M
$31.0M
Q4 24
$41.0M
$8.6M
Q3 24
$81.1M
$3.4M
Q2 24
$133.8M
$9.3M
Q1 24
$179.4M
$5.6M
Stockholders' Equity
IE
IE
IMDX
IMDX
Q4 25
$416.1M
$-31.5M
Q3 25
$280.1M
$-9.2M
Q2 25
$293.3M
$1.1M
Q1 25
$307.0M
$10.2M
Q4 24
$268.6M
$-12.3M
Q3 24
$250.1M
$9.7M
Q2 24
$289.2M
$22.7M
Q1 24
$331.5M
$11.6M
Total Assets
IE
IE
IMDX
IMDX
Q4 25
$483.3M
$25.8M
Q3 25
$386.2M
$43.9M
Q2 25
$400.5M
$50.5M
Q1 25
$414.4M
$60.4M
Q4 24
$374.9M
$35.1M
Q3 24
$375.4M
$70.2M
Q2 24
$416.3M
$74.7M
Q1 24
$461.2M
$71.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IE
IE
IMDX
IMDX
Operating Cash FlowLast quarter
$-25.7M
$-5.5M
Free Cash FlowOCF − Capex
$-25.7M
$-7.0M
FCF MarginFCF / Revenue
-2872.8%
-616.7%
Capex IntensityCapex / Revenue
4.1%
129.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-90.6M
$-25.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IE
IE
IMDX
IMDX
Q4 25
$-25.7M
$-5.5M
Q3 25
$-27.7M
$-4.5M
Q2 25
$-20.0M
$-6.3M
Q1 25
$-15.8M
$-5.9M
Q4 24
$-30.7M
$-5.4M
Q3 24
$-36.9M
$-5.5M
Q2 24
$-44.5M
$-6.0M
Q1 24
$-50.0M
$-3.8M
Free Cash Flow
IE
IE
IMDX
IMDX
Q4 25
$-25.7M
$-7.0M
Q3 25
$-27.8M
$-5.6M
Q2 25
$-21.3M
$-6.6M
Q1 25
$-15.8M
$-6.2M
Q4 24
$-32.4M
$-5.6M
Q3 24
$-36.9M
$-5.6M
Q2 24
$-45.0M
$-6.2M
Q1 24
$-50.6M
$-3.9M
FCF Margin
IE
IE
IMDX
IMDX
Q4 25
-2872.8%
-616.7%
Q3 25
-5103.9%
-2135.4%
Q2 25
-1990.1%
-1279.5%
Q1 25
-2146.5%
-288.4%
Q4 24
-2432.4%
-374.5%
Q3 24
-5506.6%
-4884.3%
Q2 24
-8372.9%
-5931.7%
Q1 24
-14064.2%
-2189.8%
Capex Intensity
IE
IE
IMDX
IMDX
Q4 25
4.1%
129.9%
Q3 25
16.9%
403.8%
Q2 25
117.6%
67.4%
Q1 25
0.3%
14.4%
Q4 24
127.3%
14.4%
Q3 24
8.8%
75.7%
Q2 24
93.7%
183.7%
Q1 24
186.7%
13.6%
Cash Conversion
IE
IE
IMDX
IMDX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-1.66×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons